Fibromyalgia- Aptinyx NYX-2925-2005- A Randomized, Double-Blind, Placebo‑Controlled Study to Assess the Efficacy and Safety of NYX-2925 in Subjects with Fibromyalgia.
Conquest Research needs volunteers for an investigational trial evaluating a medication designed to help treat patients suffering from Fibromyalgia. You may qualify if you:
Eligible participants will receive study-related care at no cost. Compensation for time and travel may be available. No medical insurance is required for participation.